Quiz 2 Material Flashcards
Haloperidol
First Generation Antipsychotic: D2 antagonist (effects on movement - extrapyramidal side effects)
Estazolam
Benzodiazepines: Bind to benzodiazepine receptor that increase the affinity of GABA for its receptor and also decrease the release of GABA
Paroxetine
Selective Serotonin Reuptake Inhibitors (SSRIs): Block the reuptake of 5-HT (serotonin) = highly selective
Zolpidem
Other Hypnotic Agents (“Benzo-like”): High affinity for the benzodiazepine binding site of GABA receptors (mimicing the effects of Benzodiazepines but with shorter durations of action)
Naltrexone
Treatment of Alcohol Dependence: Long acting opiate antagonist
Pentobarbital
Barbiturates: Bind to barbiturate receptor that increase the affinity of GABA for its receptor
Escitalopram
Selective Serotonin Reuptake Inhibitors (SSRIs): Block the reuptake of 5-HT (serotonin) = highly selective
Clomipramine
Tricyclic Antidepressants (TCAs): Block the reuptake of NE and 5-HT (serotonin) by inhibiting the transporter protein
Zaleplon
Other Hypnotic Agents (“Benzo-like”): High affinity for the benzodiazepine binding site of GABA receptors (mimicing the effects of Benzodiazepines but with shorter durations of action)
Imipramine
Tricyclic Antidepressants (TCAs): Block the reuptake of NE and 5-HT (serotonin) by inhibiting the transporter protein
Eszopiclone
Other Hypnotic Agents (“Benzo-like”): High affinity for the benzodiazepine binding site of GABA receptors (mimicing the effects of Benzodiazepines but with shorter durations of action)
Secobarbital
Barbiturates: Bind to barbiturate receptor that increase the affinity of GABA for its receptor
Carbamazepine
Drugs used to treat Mania and Bipolar Disorder
Midazolem
Benzodiazepines: Bind to benzodiazepine receptor that increase the affinity of GABA for its receptor and also decrease the release of GABA
Doxepin
Tricyclic Antidepressants (TCAs): Block the reuptake of NE and 5-HT (serotonin) by inhibiting the transporter protein
Desipramine
Tricyclic Antidepressants (TCAs): Block the reuptake of NE and 5-HT (serotonin) by inhibiting the transporter protein
Sertraline
Selective Serotonin Reuptake Inhibitors (SSRIs): Block the reuptake of 5-HT (serotonin) = highly selective
Duloxetine
Serotonin/Norepinephrine Reuptake Inhibitors (SNRIs): Block the reuptake of NE and 5-HT (serotonin) (and more effective if pain is experienced along with depression)
Ziprasidone
Second Generation Antipsychotic: Antagonist with high affinity for D2 but also D3, D4, and 5-HT receptors (does NOT have effects on movement)
Tranylcypromine
Monoamine Oxidase Inhibitors (MAOIs): Inhibit metabolism of NE, 5-HT(serotonin), and dopamine (and increasing the effectiveness of synaptic transmission by increasing the amount of transmitter replaced per action potential)
Phenobarbital
Barbiturates: Bind to barbiturate receptor that increase the affinity of GABA for its receptor
Chlorpromazine
First Generation Antipsychotic: D2 antagonist (effects on movement - extrapyramidal side effects)
Citalopram
Selective Serotonin Reuptake Inhibitors (SSRIs): Block the reuptake of 5-HT (serotonin) = highly selective
Diazepam
Benzodiazepines: Bind to benzodiazepine receptor that increase the affinity of GABA for its receptor and also decrease the release of GABA
Risperidone
Second Generation Antipsychotic: Antagonist with high affinity for D2 but also D3, D4, and 5-HT receptors (does NOT have effects on movement)
Temazepam
Benzodiazepines: Bind to benzodiazepine receptor that increase the affinity of GABA for its receptor and also decrease the release of GABA
Aripiprazole
Second Generation Antipsychotic: Antagonist with high affinity for D2 but also D3, D4, and 5-HT receptors (does NOT have effects on movement)
Amitriptyline
Tricyclic Antidepressants (TCAs): Block the reuptake of NE and 5-HT (serotonin) by inhibiting the transporter protein
Flumazenil
Benzodiazepines Antagonist: Antagonist/block the benzodiazepine binding site
Alprazolam
Benzodiazepines: Bind to benzodiazepine receptor that increase the affinity of GABA for its receptor and also decrease the release of GABA
Clozapine
Second Generation Antipsychotic: Antagonist with high affinity for D2 but also D3, D4, and 5-HT receptors (does NOT have effects on movement)
Clorazepam
Benzodiazepines: Bind to benzodiazepine receptor that increase the affinity of GABA for its receptor and also decrease the release of GABA
Nortriptyline
Tricyclic Antidepressants (TCAs): Block the reuptake of NE and 5-HT (serotonin) by inhibiting the transporter protein
Bupropion
Atypical Antidepressants: Weak dopamine and NE reuptake inhibitor (also help decrease craving and withdrawal symptoms for nicotine)
Buspirone
Other Anxiolytic Drug: Serotonin receptor agonist (can treat anxiety but can’t induce sedation)
Valprioc acid
Drugs used to treat Mania and Bipolar Disorder
Fluphenazine
First Generation Antipsychotic: D2 antagonist (effects on movement - extrapyramidal side effects)
Mirtazapine
Atypical Antidepressants: Enhances serotonin and NE neurotransmission (block presynaptic alpha-2 receptors) and potent antihistamine activity (sedative)
Thiothixene
First Generation Antipsychotic: D2 antagonist (effects on movement - extrapyramidal side effects)
Trazodone
Atypical Antidepressants: Weak inhibitor of serotonin reuptake and potent antihistamine activity (sedative)
Nefazodone
Atypical Antidepressants: Weak inhibitor of serotonin reuptake and potent antihistamine activity (sedative)
Chlordiazepoxide
Benzodiazepines: Bind to benzodiazepine receptor that increase the affinity of GABA for its receptor and also decrease the release of GABA
Selegiline
Monoamine Oxidase Inhibitors (MAOIs): Inhibit metabolism of NE, 5-HT(serotonin), and dopamine (and increasing the effectiveness of synaptic transmission by increasing the amount of transmitter replaced per action potential)
Ramelteon
Melatonin Receptor Agonist
Venlafaxine
Serotonin/Norepinephrine Reuptake Inhibitors (SNRIs): Block the reuptake of NE and 5-HT (serotonin) (and more effective if pain is experienced along with depression)
Phenelzine
Monoamine Oxidase Inhibitors (MAOIs): Inhibit metabolism of NE, 5-HT(serotonin), and dopamine (and increasing the effectiveness of synaptic transmission by increasing the amount of transmitter replaced per action potential)
Triazolam
Benzodiazepines: Bind to benzodiazepine receptor that increase the affinity of GABA for its receptor and also decrease the release of GABA
Quetiapine
Second Generation Antipsychotic: Antagonist with high affinity for D2 but also D3, D4, and 5-HT receptors (does NOT have effects on movement)
Protriptyline
Tricyclic Antidepressants (TCAs): Block the reuptake of NE and 5-HT (serotonin) by inhibiting the transporter protein
Acamprosate
Treatment of Alcohol Dependence: Poorly understood MOA
Oxazepam
Benzodiazepines: Bind to benzodiazepine receptor that increase the affinity of GABA for its receptor and also decrease the release of GABA
Lithium
Drug used to treat Mania: MOA not understood (but thought to inhibit two signal transduction pathways)
Fluoxetine
Selective Serotonin Reuptake Inhibitors (SSRIs): Block the reuptake of 5-HT (serotonin) = highly selective
Flurazepam
Benzodiazepines: Bind to benzodiazepine receptor that increase the affinity of GABA for its receptor and also decrease the release of GABA
Lorazepam
Benzodiazepines: Bind to benzodiazepine receptor that increase the affinity of GABA for its receptor and also decrease the release of GABA
Thioridazine
First Generation Antipsychotic: D2 antagonist (effects on movement - extrapyramidal side effects)
Disulfiram
Treatment of Alcohol Dependence: Inhibits aldehyde dehydrogenase (causes terrible side effects so patients would avoid alcohol to prevent side effects)